Furthermore, fludarabine also inhibited IDO expression in a breast cancer cell line exposed to supernatants prepared with anti-CD3-activated TIL from two different breast cancer samples (Figure 2B) and in a melanoma cell line treated with supernatants prepared from anti-CD3-activated T lymphocytes (Figure 2C). This evidence concerns the gene IDO1 and breast carcinoma.